Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%) Cipla informs about press release
Date: 02-04-2020Cipla has informed that the company has enclosed a press release dated 2nd April 2020 regarding ‘Cipla announces successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus’.
The above information is a part of company’s filings submitted to BSE.